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Abstract
Purpose To assess the risk factors for adverse outcomes in attempted vaginal preterm breech deliveries.
Methods A retrospective case–control study, including 2312 preterm breech deliveries (24 + 0 to 36 + 6 gestational weeks) 
from 2004 to 2018 in Finland. The preterm breech fetuses with adverse outcomes born vaginally or by emergency cesarean 
section were compared with the fetuses without adverse outcomes with the same gestational age. A multivariable logistic 
regression analysis was used to calculate the risk factors for adverse outcomes (umbilical arterial pH below 7, 5-min Apgar 
score below 4, intrapartum stillbirth and neonatal death < 28 days of age).
Results Adverse outcome in vaginal preterm breech delivery was associated with maternal obesity (aOR 32.19, CI 2.97–
348.65), smoking (aOR 2.29, CI 1.12–4.72), congenital anomalies (aOR 4.50, 1.56–12.96), preterm premature rupture of 
membranes (aOR 1.87, CI 1.00–3.49), oligohydramnios (28–32 weeks of gestation: aOR 6.50, CI 2.00–21.11, 33–36 weeks 
of gestation: aOR 19.06, CI 7.15–50.85), epidural anesthesia in vaginal birth (aOR 2.44, CI 1.19–5.01), and fetal growth 
below the second standard deviation (28–32 weeks of gestation: aOR 5.89, CI 1.00–34.74, 33–36 weeks of gestation: aOR 
12.27, CI 2.81–53.66).
Conclusion The study shows that for each subcategory of preterm birth, there are different risk factors for adverse neonatal 
outcomes in planned vaginal breech delivery. Due to the extraordinary increased risk of adverse outcomes, we would recom-
mend a planned cesarean section in very preterm breech presentation (28 + 0 to 32 + 6 weeks) with severe maternal obesity, 
oligohydramnios, or fetal growth restriction and in moderate to late preterm breech presentation (33 + 0 to 36 + 6 weeks) 
with oligohydramnios or fetal growth restriction.
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Abbreviations
ICD-10  International Statistical Classification of 
Diseases and Related Health Problems 10th 
Revision
BMI  Body mass index
PPROM  Preterm premature rupture of membranes
SD  The second standard deviation
WHO  World Health Organization
OR  Crude odds ratio
Cl  Confidence interval
aOR  Adjusted odds ratio
Introduction
Around 4% of all fetuses are in breech presentation at birth 
[1, 2]. In preterm labor breech presentation is more common 
than in term and every fourth of all fetuses born extremely 
preterm are in breech presentation at birth [3–6]. Breech 
presentation in preterm and term pregnancies is associated 
with obstetric risk factors for adverse neonatal outcomes, 
such as oligohydramnios, fetal growth restriction, and con-
genital anomalies [7–9]. Vaginal breech delivery at term 
is a risk factor for short-term neonatal morbidity [10], and 
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therefore, vaginal breech delivery is feasible only for well-
selected patients [11–15]. In vaginal preterm breech deliv-
ery, the situation is still unclear in which cases a vaginal 
delivery is associated with an increased adverse neonatal 
outcome. The royal college of obstetricians and gynae-
cologists stated in their breech delivery guidelines that a 
spontaneous vaginal breech labor in preterm pregnancies 
is not contraindicated if an immediate cesarean delivery 
is not needed for maternal or fetal reasons [16]. In many 
countries, cesarean section is the most common way of 
delivery for preterm breech fetuses as several studies have 
suggested that preterm breech fetuses delivered by a primary 
cesarean section have a significantly lower risk of neonatal 
mortality compared with those delivered vaginally [17–19]. 
Cochrane review 2013 could not recommend the mode of 
birth instead of another in preterm deliveries irrespectively 
of fetal presentation [20].
Earlier studies were able to identify risk factors for 
adverse neonatal outcome in vaginal term breech deliver-
ies [8, 11, 21], but there is no research available regard-
ing risk factors for adverse neonatal outcome in vaginal 
preterm breech delivery. Our study aims to identify risk 
factors for adverse neonatal outcomes in vaginal preterm 
delivery. This information is needed,  since every tenth 
baby is born preterm [20] and many of them are in a breech 
position. Obstetricians need adequate information to iden-
tify those women who should give birth by cesarean section 
in any case.
Materials and methods
The study is a population-based case–control study, includ-
ing all singleton breech deliveries from 24 to 36 completed 
weeks of gestation that were delivered vaginally or by emer-
gency cesarean section in Finland. The study period ranged 
from January 1st, 2004 to December 31st, 2018. The popu-
lation included altogether 2312 preterm breech deliveries.
We utilized the data of the national medical birth register 
and the hospital discharge register maintained by the Finnish 
Institute for Health and Welfare. The authorization to use 
the data was obtained from the Finnish Institute for Health 
and Welfare as required by the national data protection law 
in Finland (reference number THL/652/5.05.00/2017). All 
maternity hospitals are obligated to report clinical data 
on national registers. The national medical birth register 
includes all live births and stillbirths from 22 weeks or from 
500 grams. The hospital discharge register contains infor-
mation on all inpatient and outpatient care in public hospi-
tals including data from maternal, obstetric, and neonatal 
care. International Statistical Classification of Diseases and 
Related Health Problems 10th Revision, ICD-10, is used to 
code the information.
We limited the study population to the fetuses born vagi-
nally or by emergency cesarean section, as we wanted to 
research intrapartum risk factors of preterm breech deliver-
ies. We excluded multiple gestations, antepartum stillbirths, 
deliveries before 24 weeks of gestation, and term pregnan-
cies from our study. The deliveries complicated with uterus 
rupture (ICD-10 O71.0, O71.1), placental abruption, and 
severe congenital anomalies such as chromosomal and heart 
defects diagnosed at birth hospital (ICD-10 Q90–Q99, Q20, 
Q22, Q28) that might have affected on the newborns surviv-
ing, were excluded from the study.
The primary outcome of the study was an adverse out-
come defined as the following: umbilical arterial pH below 
7, a 5-min Apgar score below 4, intrapartum stillbirth or 
neonatal death between 0 and 27 days of age. The following 
maternal variables were included in the analysis: age, parity, 
pre-pregnancy body mass index (BMI), smoking, in vitro 
fertilization, history of cesarean section, and maternal hypo- 
or hyperthyroidism (ICD-10 E03, E05). The obstetric risk 
factors assessed in the analysis were: maternal gestational 
diabetes (ICD-10 O24.4) and other diabetes treated with 
insulin (ICD-10 O24.0), arterial high blood pressure or 
preeclampsia (ICD-10 O13, O14), oligohydramnios (ICD-
10 O41.0), and preterm premature rupture of membranes 
(PPROM) (ICD-10 O42). Induction of labor and the use of 
epidural anesthesia during labor were also included in the 
variables. The fetal factors such as sex, fetal birthweight 
below the second standard deviation (SD), and congenital 
fetal anomalies, as defined in the register of congenital mal-
formations, were included in the analysis.
We divided the study population into three groups accord-
ing to the World Health Organization (WHO) definitions of 
preterm deliveries. A fetus born alive before 37 completed 
weeks of pregnancy is defined as preterm birth, according to 
WHO. WHOs recommended subcategories based on gesta-
tional age were used in the division of the groups: extremely 
preterm (less than 28 pregnancy weeks), very preterm (28 
to 32 pregnancy weeks), and moderate to late preterm (32 
to 37 pregnancy weeks).
The preterm breech fetuses with adverse outcomes were 
compared with the fetuses without adverse outcomes with 
the same gestational age. Each study group, divided accord-
ing to WHO classification, was separately adjusted.
We used SPSS for 19 to perform the statistical analyses. 
The adjustments with a binary logistic regression model 
were calculated for the study population. A Chi squared test 
or Fisher’s exact test was used when appropriate. Odds ratio 
(ORs) and corresponding 95% confidence interval (CIs) for 
each risk factor for adverse outcomes were calculated, and p 
values below ≤ 0.05 were considered statistically significant.
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Results
Our study included 2312 singleton preterm breech deliv-
eries born between 24 + 0 and 36 + 6 gestational weeks 
in 2004–2018 in Finland. Out of these deliveries, 7.4% 
(172 fetuses) had adverse outcomes. The risk of having 
adverse outcomes was over tenfold in the fetuses born in 
24 + 0 to 27 + 6 weeks of gestation and threefold in 28 + 0 
to 32 + 6 weeks of gestation, compared to the late preterm 
breech deliveries (Fig. 1).
In 24 to 28 weeks of gestational age, 78 out of 250 breech 
deliveries (31.2%) had an adverse outcome. In these ges-
tational weeks, the only significant risk factor in a trial of 
vaginal breech labor emerging from our study was PPROM 
(aOR 1.87, CI 1.00–3.49) (Table 1).
Among very preterm breech deliveries (28 + 0 to 
32 + 6 weeks of gestation), nearly one out of ten fetuses 
(47/518, 9.1%) had adverse outcomes. Severe maternal 
obesity (aOR 32.19, CI 2.97–348.65), oligohydramnios 
(aOR 6.50, CI 2.00–21.11), congenital anomalies (aOR 
4.50, 1.56–12.96), and fetal growth restriction (aOR 
5.89, CI 1.00–34.74) increased the risks for adverse out-
comes in these gestational weeks. Nulliparity (aOR 0.43, 
CI 0.18–0.99) and maternal preeclampsia or high blood 
pressure (aOR 0.21, CI 0.05–0.96) were associated with a 
decreased risk of adverse outcome (Table 2).
In late preterm deliveries, the adverse outcomes became 
less frequent, as in 33 to 36 gestational weeks, only 47 
out of 1544 deliveries (3.0%) had an adverse outcome. 
Significant risk factors for adverse outcomes in late pre-
term breech deliveries in our study were maternal smoking 
(aOR 2.29, CI 1.12–4.72), oligohydramnios (aOR 19.06, CI 
7.15–50.85), epidural anesthesia in vaginal birth (aOR 2.44, 
CI 1.19–5.01), and fetal growth restriction (aOR 12.27, CI 
2.81–53.66) (Table 3).
Discussion
Our study shows that for each subcategory of preterm birth, 
there are different risk factors for adverse neonatal outcomes 
in planned vaginal preterm breech delivery. In extremely 
preterm breech deliveries (24 + 0 to 27 + 6 weeks) PPROM 
was associated with adverse neonatal outcomes. In very 
preterm breech deliveries (28 + 0 to 32 + 6 weeks) severe 
maternal obesity, oligohydramnios, congenital anomalies, 
and fetal growth restriction were associated with a higher 
risk of adverse neonatal outcome. In moderate to late pre-
term breech deliveries (33 + 0 to 36 + 6 weeks) maternal 
smoking, oligohydramnios, epidural anesthesia, and fetal 
growth restriction were identified as risk factors.
Oligohydramnios was found to increase the adverse out-
comes 6.5-fold for very preterm and 19-fold for moderate 
to late preterm breech deliveries in our study. The results 
are supported by the previous literature that has shown oli-
gohydramnios to be a risk factor for adverse perinatal out-
comes in term breech pregnancies [8]. Oligohydramnios is 
linked to diminished fetal movements, compression of the 
umbilical cord, insufficiency of the placental as well as fetal 














































Fig. 1  Breech presentation and adverse outcomes during the period of 2004–2018 in Finland
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aspiration of meconium [8, 22, 23]. Besides, previous stud-
ies have shown that a low amniotic fluid amount is linked 
with lower Apgar scores, a higher risk of neonatal acidosis 
and cesarean section as the mode of delivery due to fetal 
distress [22].
Fetal growth restriction in term is a well-known con-
traindication for vaginal breech delivery, since it is indis-
putably linked to severe adverse perinatal outcomes such as 
hypoxic injuries and even neonatal death [8, 21]. Our results 
were coherent; fetal growth restriction (< − 2SD/IUGR) in 
planned vaginal breech delivery increased remarkably the 
risk for perinatal morbidity also in very preterm (sixfold) 
and in moderate to late preterm (12-fold) deliveries. Growth 
restricted fetuses might suffer more easily from distress 
during labor, and potential entrapment of the head during 
vaginal labor might increase the risks. Our study showed 
that smoking increased adverse outcomes in 33 to 36 weeks 
of gestation. Smoking is a major risk factor for intrauter-
ine growth restriction and it is associated with obstetric 
complications such as placental abruption and placenta pre-
via, as well as preterm birth itself [24, 25].
Maternal obesity was shown as a risk for neonatal health 
in very preterm breech deliveries. The risk for adverse out-
come increased 32-fold, if women with a BMI above 35 
attempted a trial of vaginal delivery among very preterm 
pregnancies. Antenatal and intrapartum obstetric compli-
cations, as well as perinatal morbidity and mortality, are 
known to be increased in obese mothers [7, 26, 27]. Mater-
nal obesity is associated with preterm delivery itself, instru-
mental delivery, and cesarean section as a mode of birth 
[26, 27]. Also, evaluation of fetal wellbeing might be more 
difficult in obese women [26]. Our personal opinion is that 
the massive obesity has an effect on the birth channel and 
that a very preterm fetus is not able to path through the birth 
channel smoothly, through excessive soft tissue resistance.
One of the essential findings of our study was that the 
induction of labor did not increase the risks in preterm 
breech deliveries (24–27 weeks of gestation: aOR 0.50, p 
value 0.787, 28–32 weeks of gestation: aOR 2.13, p value 
Table 1  Unadjusted and adjusted odds ratios for risk factors for adverse outcomes in 24 + 0 to 27 + 6 weeks of gestational age fetuses in breech 
presentations 2004–2018 in Finland
BMI body mass index, PPROM preterm premature rupture of membranes




Adjusted OR 95% confidence limits
N = 172 N = 78
Maternal age < 25 5/2.9% 4/5.1% 2.04 0.48–8.66
Maternal age ≥ 35 48/27.9% 23/29.5% 1.31 0.65–2.58
Maternal smoking 30/17.4% 13/16.7 0.91 0.41–2.04
Nulliparous 76/44.2% 42/53.8% 1.82 0.93–3.54
Multipara ≥ 3 deliveries 25/14.5% 12/15.4% 1.37 0.45–4.23
BMI ≥ 30 25/14.5% 11/14.1% 1.20 0.41–3.50
BMI ≥ 35 12/7.0% 4/5.1% 0.65 0.13–3.16
History of induced abortion 36/20.9% 41/17.9% 0.85 0.39–1.83
History of miscarriage 48/27.9% 29/37.2% 1.64 0.89–3.03
History of cesarean section 18/10.5% 9/11.5% 1.13 0.41–2.56
Assisted reproduction technology 7/4.1% 0/0.0%
Diabetes mellitus type I 2/1.2% 2/2.6% 0.34 0.04–2.63
Diabetes mellitus type II 0/0.0% 1/1.3%
Gestational diabetes 10/5.8% 4/5.1% 0.99 0.24–4.12
Pre-eclampsia/high blood pressure 20/11.6% 4/5.1% 0.49 0.15–1.58
Oligohydramnios 4/2.3% 2/2.6% 0.88 0.15–5.34
Placenta previa 3/1.7% 1/1.3% 0.54 0.05–5.99
PPROM 0/0.0% 31/39.7% 1.87 1.00–3.49
Any congenital anomaly 0/0.0% 2/2.6% 1.98 0.29–13.59
Induced delivery 47/27.3% 1/1.3% 0.50 0.04–5.97
Epidural anesthesia in vaginal birth 3/1.7% 3/9.4% 1.18 0.39–3.59
Gestational age at delivery mean in days 184/8 179/8
Fetal growth restriction (birth weight < 2SD) 0/0.0% 1/1.3%
Neonatal sex (female) 87/50.6% 34/43.6% 0.75 0.42–1.34
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0.103, 33–36 weeks of gestation: aOR 1.38, p value 0.105). 
Contrary findings were found in a recent meta-analysis 
(2018) as induction of term breech labor was found to 
increase the risk of perinatal morbidity and cesarean sec-
tions [28]. However, Macharey et al. found no association 
between induction of term breech labor and neonatal mor-
bidity, but the rate of vaginal deliveries was remarkably 
lower if term breech labor was induced compared to the 
spontaneous breech deliveries [29]. Induction of term labor 
in breech presentation was established as safe as planned 
cesarean delivery also in observational prospective study 
2019 [30].
Our results showed a connection between epidural anes-
thesia in vaginal breech labor and adverse outcomes in 
moderate to late preterm deliveries. Earlier studies have 
already shown a connection between epidural anesthe-
sia and prolonged labor in term breech deliveries [31]. 
Furthermore, epidural anesthesia during labor is associ-
ated with increased augmentation with oxytocin and over 
twofold higher risk of adverse outcomes in term breech 
deliveries [8, 31]. It has been speculated whether adverse 
outcomes are due to the fact that epidural anesthesia is 
more used in prolonged labors or epidural anesthesia itself 
increases the duration of labor [8, 31].
Interestingly, in our study pre-eclampsia or high blood 
pressure decreased the odds of adverse outcomes in very 
preterm breech deliveries. However, pre-eclampsia is 
a well-identified risk factor for maternal and neonatal 
mortality and morbidity [32]. Pre-eclampsia is associ-
ated with intrauterine growth restriction and congenital 
anomalies [32–34], in which both conditions increased 
the adverse perinatal outcomes in our study among very 
preterm deliveries. Our contradictory results might be 
explained by the fact that the small number of cases may 
not have had enough power to detect differences between 
the groups. Besides, maternal obstetric risk factors such 
as pre-eclampsia or high blood pressure may be consid-
ered as a contraindication for vaginal delivery and thus 
these women have more often a planned cesarean section 
Table 2  Unadjusted and adjusted odds ratios for risk factors for adverse outcomes in 28 + 0 to 32 + 6 weeks of gestational age fetuses in breech 
presentations 2004–2018 in Finland
BMI body mass index, PPROM preterm premature rupture of membranes




Adjusted OR 95% confidence limits
N = 471 N = 47
Maternal age < 25 6/1.3% 0/0.0%
Maternal age ≥ 35 123/26.1% 12/25.5% 1.02 0.46–2.22
Maternal smoking 80/17.0% 6/12.8% 0.54 0.20–1.45
Nulliparous 232/49.3% 14/29.8% 0.43 0.18–0.99
Multipara ≥ 3 deliveries 61/13.0% 9/19.1% 1.31 0.39–4.44
BMI ≥ 30 67/14.2% 6/12.8% 0.16 0.02–1.28
BMI ≥ 35 18/3.8% 5/10.6% 32.19 2.97–348.65
History of induced abortion 72/15.3% 10/21.3% 1.60 0.69–3.71
History of miscarriage 111/23.6% 14/29.8% 1.03 0.48–2.18
History of cesarean section 72/15.3% 15/31.9% 1.79 0.79–4.06
Assisted reproduction technology 20/4.2% 0/0.0%
Diabetes mellitus type I 24/5.1% 1/2.1% 2.53 0.27–24.17
Diabetes mellitus type II 3/0.6% 0/0.0%
Gestational diabetes 43/9.1% 3/6.4% 1.66 0.40–6.89
Pre-eclampsia/High blood pressure 74/15.7% 2/4.3% 0.21 0.05–0.96
Oligohydramnios 12/2.5% 7/14.9% 6.50 2.00–21.11
Placenta previa 6/1.3% 0/0.0% 0.55 0.26–1.17
PPROM 152/32.3% 12/25.5% 0.55 0.26–1.17
Any congenital anomaly 19/4.0% 8/17.0% 4.50 1.56–12.96
Induced delivery 11/2.3% 3/6.4% 2.13 0.44–10.36
Epidural anesthesia in vaginal birth 25/26.3% 4/25.0% 1.48 0.47–4.63
Gestational age at delivery mean in days 216/10 210/10
Fetal growth restriction (birth weight < 2SD) 6/1.3% 2/4.3% 5.89 1.00–34.74
Neonatal sex (female) 218/46.3% 17/36.2% 0.74 0.37–1.48
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as mode of delivery. These circumstances might cause bias 
in the results [35].
Other authors have shown primiparous women to have 
more adverse perinatal outcomes [36]. Furthermore, primi-
parity is linked to low birth weight in term pregnancies [37], 
and in our results, fetal growth restriction in preterm breech 
deliveries seemed to increase the risks. Nevertheless, primi-
parity in preterm breech deliveries was not found as a risk 
for perinatal morbidity in our study, and in contrary, primi-
parity appeared as a protective factor in very preterm vaginal 
breech delivery. This finding may partly be explained that 
the mode of birth is more likely primary cesarean section in 
nulliparous women when the fetus is in a breech position.
 Congenital anomalies in term breech pregnancies are 
known risks for perinatal morbidity and mortality [7, 9, 
38], and our study showed similar results among very 
preterm breech fetuses. In addition, other studies have 
linked oligohydramnios, fetal growth restriction, maternal 
obesity, and high blood pressure to increased congenital 
anomalies [24, 27, 39], and as shown before, these factors 
were risks for adverse outcomes in our study as well. 
However, in many cases of severe congenital anomalies, 
vaginal delivery is favorable also in breech deliveries to 
minimize maternal morbidity [40].
In extremely preterm breech deliveries over 30% had 
adverse outcomes. In this group the only risk factor found 
for adverse outcomes was PPROM. The extremely pre-
term delivery itself is a major risk for short-term neonatal 
morbidity [41], and this fact may be the reason why we 
could not identify more risk factors. Sephton S showed 
PPROM to be associated with a significant risk of neonatal 
morbidity partly due to infections and placental abruptions 
[42–44]. Preterm fetuses with PPROM and born vaginally 
may not tolerate the contractions during labor or the com-
pression when descending in the birth canal [45]. Preterm 
breech deliveries complicated with PPROM may also have 
more difficulties with the delivery of the aftercoming head 
[46]. In a Cochrane review (2017) Bond and colleagues 
pointed out that despite PPROM before 37 weeks’ gesta-
tion and without contraindications, expectant management 
Table 3  Unadjusted and adjusted odds ratios for risk factors for adverse outcomes in 33 + 0 to 36 + 6 weeks of gestational age fetuses in breech 
presentations 2004–2018 in Finland
BMI body mass index, PPROM preterm premature rupture of membranes




Adjusted OR 95% confidence limits
N = 1497 N = 47
Maternal age < 25 31/2.1% 1/2.1% 0.49 0.05–4.74
Maternal age ≥ 35 362/24.2% 11/23.4% 0.94 0.44–2.02
Maternal smoking 227/15.2% 14/29.8% 2.29 1.12–4.72
Nulliparous 872/58.2% 22/46.8% 0.87 0.42–1.83
Multipara ≥ 3 deliveries 116/7.7% 7/14.9% 1.42 0.43–4.68
BMI ≥ 30 155/10.4% 8/17.0% 0.92 0.25–3.35
BMI ≥ 35 57/3.8% 5/10.6% 2.88 0.54–15.19
History of induced abortion 174/11.6% 7/14.9% 0.98 0.39–2.44
History of miscarriage 355/23.7% 10/21.3% 0.69 0.31–1.51
History of cesarean section 172/11.5% 8/17.0% 1.82 0.71–4.63
Assisted reproduction technology 61/4.1% 0/0.0%
Diabetes mellitus type I 24/1.6% 1/2.1% 0.43 0.05–3.56
Diabetes mellitus type II 3/0.2% 1/2.1% 0.11 0.01–1.39
Gestational diabetes 153/10.2% 5/10.6% 0.99 0.36–2.77
Pre-eclampsia/High blood pressure 106/7.1% 1/2.1% 0.20 0.03–1.60
Oligohydramnios 23/1.5% 8/17.0% 19.06 7.15–50.85
Placenta previa 20/1.3% 1/2.1% 2.13 0.26–17.41
PPROM 406/27.1% 9/19.1% 0.73 0.33–1.61
Any congenital anomaly 111/7.4% 4/8.5% 0.89 0.27–2.99
Induced delivery 123/8.2% 7/14.9% 1.38 0.51–3.71
Epidural anesthesia in vaginal birth 250/42.6% 15/55.6% 2.44 1.19–5.01
Gestational age at delivery mean in days 246/9 249/7
Fetal growth restriction (birth weight < 2SD) 11/0.7% 3/6.4% 12.27 2.81–53.66
Neonatal sex (female) 703/47. 0% 26/55.3% 1.39 0.74–2.62
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in careful evaluation is associated with good neonatal out-
comes [47].
Our study offers essential information about the risks of 
adverse outcomes in preterm breech deliveries. This is the 
first study that was able to identify risk factors for adverse 
neonatal outcomes in planned vaginal preterm breech 
delivery. Understanding the risks for adverse outcomes is 
essential for the decision-making on the mode of delivery 
when treating preterm breech deliveries. Obstetricians can 
now select for preterm breech presentation those women 
who should give birth by cesarean section in any case. 
Some of the risk factors like oligohydramnios, congenital 
anomalies, and fetal growth restriction were similar as in 
planned vaginal breech delivery at term [8, 21], but others, 
like severe maternal obesity and PPROM, were not known 
as risk factors for breech deliveries overall. This study is a 
unique population-based case–control study of the subject 
and offers valuable information for decision-making when 
treating preterm breech deliveries.
There are, however, few limitations in our study. Designed 
as a retrospective trial, we are exposed to the possibility of 
a typical bias of retrospective case–control studies. Addi-
tionally, data were restricted to the information of the data 
bank. In a few risk factors, we might have lacked statistical 
power to detect the risks of adverse outcomes, as there were 
only a few patients in the group. Nevertheless, our study was 
population-based and included over 2300 vaginal preterm 
breech deliveries from 14 years. Because there are no private 
birth hospitals in Finland, the treatment of the deliveries are 
homogenous and comparative.
Conclusion
 We recommend a planned cesarean section for women 
with severe maternal obesity (BMI > 35), oligohydramnios, 
or fetal growth restriction in very preterm breech deliver-
ies (28 + 0 to 32 + 6 weeks) and for women with oligohy-
dramnios or a fetus with fetal growth restriction (< 2 SD) 
in moderate to late preterm breech deliveries (33 + 0 to 
36 + 6 weeks).
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